There are calls for the Therapeutic Goods Administration (TGA) to greenlight a breakthrough medication with the potential to slow the progression of Alzheimer’s disease. The Federal Drug Administration (FDA) recently approved humanised monoclonal antibody Lecanemab for use in patients with the neurodegenerative disease, in the wake of promising clinical trial outcomes. The medication, marketed as…

Read More

Team VIVA! was dressed to impress at the annual PRIA Golden Target Awards (GTAs) held at the Sofitel Darling Harbour, Sydney, last night (Thursday, December 1, 2022).  A show-stopping 146 finalists representing 35 categories assembled for Australia’s longest-running, and most prestigious public relations and communications awards that both celebrate, and recognise, individuals, agencies and campaigns demonstrating strategic…

Read More

VIVA! Communications marked the 18th annual PRIME Awards in style last night (Thursday, November 10, 2022) together with our much-valued clientele, Edwards Lifesciences and Dr Falk Pharma,  and Australian representatives from the pharmaceutical industry, at the Sofitel Wentworth Sydney Hotel.   Hosted by comedian, musician and former member of ABC TV’s satirical program, The Chaser,…

Read More

Today marks an important milestone in the history of VIVA! Communications. I founded the health + wellness communications agency two decades ago today, after working for a number of multi-national PR agencies in Australia, and in various in-house comms-related roles. Armed with brazen ambition, a passion for health and wellness, an unquenchable thirst for independence,…

Read More

Non-surgical treatment now available on Medicare Of the estimated 66,500 Australians living with aortic stenosis, 9 in 10 are not undergoing treatment each year for the potentially life-threatening disease. However, the inclusion of transcatheter aortic valve implantation (TAVI) on Medicare from July 1, 2022, is expanding access to the minimally invasive treatment option for all…

Read More